Drug Target Commons 2.0: a community platform for systematic analysis of drug–target interaction profiles

Ziaurrehman Tanoli(University of Helsinki), Zaid Alam(University of Helsinki), Markus Vähä‐Koskela(University of Helsinki), Balaguru Ravikumar(University of Helsinki), Alina Malyutina(University of Helsinki), Alok Jaiswal(University of Helsinki), Jing Tang(University of Helsinki), Krister Wennerberg(University of Copenhagen), Tero Aittokallio(University of Helsinki)
Database
January 1, 2018
Cited by 75Open Access
Full Text

Abstract

Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioactivity data integration and standardization for comprehensive mapping, reuse and analysis of compound-target interaction profiles. End users can search, upload, edit, annotate and export expert-curated bioactivity data for further analysis, using an application programmable interface, database dump or tab-delimited text download options. To guide chemical biology and drug-repurposing applications, DTC version 2.0 includes updated clinical development information for the compounds and target gene-disease associations, as well as cancer-type indications for mutant protein targets, which are critical for precision oncology developments.


Related Papers

No related papers found

Powered by citation graph analysis